Personalised treatment innovations in the field of rheumatology are transforming patient care and outcomes, driven by significant advances in understanding the origins of rheumatological diseases.
Professor Antonio Almeida has been at the forefront of clinical haematology for more than 20 years and last year he became president of the European Hematology Association (EHA). Speaking to Julie ...
In September, the Royal College of Paediatrics and Child Health published its updated position statement on air pollution in the UK. Dr Emily Parker, RCPCH Clinical Fellow and one of the position ...
Genetics partly influence the shape of the heart’s left and right ventricles, a study shows for the first time, with the findings potentially helping to refine cardiovascular disease (CVD) risk ...
Professor Philippe L. Pereira – CIRSE president and director of the Center of Radiology, Minimally Invasive Therapies and Nuclear Medicine at the Academic Hospital of Ruprecht-Karls-University ...
A second interim analysis of the KEYNOTE-671 trial has shown that adding perioperative pembrolizumab to neoadjuvant chemotherapy for early-stage non-small-cell lung cancer (NSCLC) is effective and ...
Our latest Clinical Excellence in Respiratory Care event included a fascinating panel discussion on managing pulmonary hypertension as a multidisciplinary team (MDT). Here, you have exclusive access ...